Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO

Objective  Severe cases of coronavirus disease 2019 (COVID-19) can require continuous renal replacement therapy (CRRT) and/or extracorporeal membrane oxygenation (ECMO). Unfractionated heparin (UFH) to prevent circuit clotting is mandatory but monitoring is complicated by (pseudo)-heparin resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Streng, Alexander S., Delnoij, Thijs S.R., Mulder, Mark M.G., Sels, Jan Willem E.M., Wetzels, Rick J.H., Verhezen, Paul W.M., Olie, Renske H., Kooman, Jeroen P., van Kuijk, Sander M.J., Brandts, Lloyd, ten Cate, Hugo, Lorusso, Roberto, van der Horst, Iwan C.C., van Bussel, Bas C.T., Henskens, Yvonne M.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676995/
https://www.ncbi.nlm.nih.gov/pubmed/33235946
http://dx.doi.org/10.1055/s-0040-1719083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676995/
https://www.ncbi.nlm.nih.gov/pubmed/33235946
http://dx.doi.org/10.1055/s-0040-1719083

Ejemplares similares